According to a new market report, the global PLGA (poly(lactic-co-glycolic acid)) market is expected to grow from USD 125 million in 2024 to USD 321 million by 2030, registering a strong CAGR of 16.6%. The growth is fueled by expanding applications across healthcare, biotechnology, packaging, textiles, and agriculture.
PLGA is highly valued for its biodegradability and biocompatibility, making it ideal for sustainable applications. The packaging sector is projected to be the fastest-growing end-use industry, as demand rises for eco-friendly, biodegradable alternatives to traditional plastics.
North America is expected to dominate the market in value terms, driven by its advanced healthcare infrastructure, pharmaceutical R&D, and regulatory support. Major players in the market include Evonik, Corbion, Ashland, Mitsui Chemicals, and Merck, among others.
PLGA’s role in drug delivery systems, tissue engineering, and medical implants continues to expand, supported by innovations in manufacturing and biomedical research.